Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Germline CHEK2 mutations in patients with myeloid neoplasms.
Leukemia. 2024 Apr;38(4):908-911. doi: 10.1038/s41375-024-02179-w. Epub 2024 Feb 20.
Leukemia. 2024.
PMID: 38378842
No abstract available.
Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens.
Sébert M, Freiman L, Chaffaut C, Guerci A, Peterlin P, Thépot S, Beyne-Rauzy O, Park S, Cluzeau T, Chermat F, Fenaux P, Preudhomme C, Clappier E, Chevret S, Adès L, Duployez N, Duchmann M.
Sébert M, et al. Among authors: freiman l.
Leukemia. 2024 Apr;38(4):918-922. doi: 10.1038/s41375-024-02180-3. Epub 2024 Feb 17.
Leukemia. 2024.
PMID: 38368440
No abstract available.
Item in Clipboard
Replicating Reducing the Risk: 12-Month Impacts of a Cluster Randomized Controlled Trial.
Kelsey M, Blocklin M, Layzer J, Price C, Juras R, Freiman L.
Kelsey M, et al. Among authors: freiman l.
Am J Public Health. 2016 Sep;106(S1):S45-S52. doi: 10.2105/AJPH.2016.303409.
Am J Public Health. 2016.
PMID: 27689492
Free PMC article.
Item in Clipboard
Cite
Cite